David E. Gloriam

14.6k citations
107 papers · 8.9k · 6 hit papers · h-index 39

Impact in

    • Neuropeptides and Animal Physiology
    • Neuroscience and Neuropharmacology Research
    • Receptor Mechanisms and Signaling
    • Chemical Synthesis and Analysis
    • Protein Kinase Regulation and GTPase Signaling

Papers in

    • Receptor Mechanisms and Signaling 86
    • Chemical Synthesis and Analysis 16
    • Protein Kinase Regulation and GTPase Signaling 11
    • Nicotinic Acetylcholine Receptors Study 6
    • Neuropeptides and Animal Physiology 44
    • Neuroscience and Neuropharmacology Research 10

David E. Gloriam

107 papers receiving 8.8k citations

David E. Gloriam's Hit Papers

GPCR drug discovery: new agents, targets and indications 2025 · 65 citations
650+3+6Years since publication50010001.5k

Peers

David E. Gloriam
Comparison fields: 5 of 126
  • Cellular and Molecular Neuroscience 3.6k
  • Molecular Biology 6.8k
  • Computational Theory and Mathematics 1.2k
  • Sensory Systems 283
  • Physiology 250
Replace Aashish Manglik with:
Aashish Manglik United States
Terry Kenakin United States
Peter Gmeiner Germany
Hee‐Jung Choi South Korea
Daniel M. Rosenbaum United States
Foon Sun Thian United States
Gye Won Han United States
Michael A. Hanson United States
Fiona H. Marshall United Kingdom
Marta Filizola United States
David E. Gloriam relative to Aashish Manglik United States Aashish Manglik's profile →
Citations per field
00.5×1.5×
Aashish Manglik · 1×
Citations per year

Countries citing papers authored by David E. Gloriam

Since Specialization
Citations

This map shows the geographic impact of David E. Gloriam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Gloriam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Gloriam more than expected).

Fields of papers citing papers by David E. Gloriam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Gloriam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Gloriam. The network helps show where David E. Gloriam may publish in the future.

Co-authors

The 25 scholars most cited alongside David E. Gloriam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David E. Gloriam Line = papers co-authored together David E. Gloriam links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Trends in GPCR drug discovery: new agents, targets and indications
Hit paper breakdown →
20171916
2
Pharmacogenomics of GPCR Drug Targets
Hit paper breakdown →
2017433
3
GPCRdb in 2018: adding GPCR structure models and ligands
Hit paper breakdown →
2017389
4 2015368
5 2014362
6 2006321
7 2017283
8
GPCRdb in 2021: integrating GPCR sequence, structure and function
Hit paper breakdown →
2020262
9 2010227
10 2003226
11 2021192
12 2004187
13 2021182
14 2019181
15 2007156
16
Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs
Hit paper breakdown →
2022155
17 2016154
18 2022134
19 2022130
20 2013111

About David E. Gloriam

David E. Gloriam is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience, Computational Theory and Mathematics, Radiology, Nuclear Medicine and Imaging and Spectroscopy, having authored 107 papers that have together received 8.9k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (86 papers), Neuropeptides and Animal Physiology (44 papers), Computational Drug Discovery Methods (19 papers), Chemical Synthesis and Analysis (16 papers), Monoclonal and Polyclonal Antibodies Research (13 papers), Protein Kinase Regulation and GTPase Signaling (11 papers), Neuroscience and Neuropharmacology Research (10 papers) and Nicotinic Acetylcholine Receptors Study (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (3.6k citations), Molecular Biology (6.8k citations), Computational Theory and Mathematics (1.2k citations), Sensory Systems (283 citations) and Physiology (250 citations). David E. Gloriam has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Alexander S. Hauser, Helgi B. Schiöth, Misty M. Attwood, Mathias Rask‐Andersen, Robert Fredriksson, Helgi B. Schiöth, Christian Munk, Kasper Harpsøe, Stefan Mordalski and Vignir Ísberg. Their work appears in journals such as Journal of Medicinal Chemistry, Nucleic Acids Research, Scientific Reports, Nature and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact